Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
Privacy is essential to the exercise of free speech, free thought, and free association. Creative Biogene is committed to protecting your privacy. This Privacy Policy describes the types of personal information we collect about individuals through our website, how we may use the information, and with whom we may share it. The Privacy Policy also describes how individuals can contact us about our privacy practices and to exercise their rights.
By using our website at or any website of ours, you agree to this policy. By providing your consent, you agree to allow us use your email address, phone number, and postal address to communicate with you about our products and services.
Please note that it is important not to submit sensitive personal information, such as racial or ethnic origin, political beliefs, philosophical or religious beliefs, membership of a trade union or political party, physical or mental health or genetic makeup, addictions, sexual life, the commission of criminal offences or proceedings and associated penalties or fines. If you provide such sensitive personal information to Creative Biogene inadvertently, rest assured the information will be promptly deleted.
We will share your data with certain recipients as an essential part of being able to provide you with products and services, to run our events, and to enable us to run our business effectively. Such recipients include:
Our group companies. our subsidiaries (i.e. any organization we own or control) or our holding company or ultimate holding company (i.e. any organization that owns or controls us) and any subsidiaries they own. These companies will only use your personal information in the same way as we can under this privacy policy.
Law enforcement, regulators and other parties for legal reasons. Sometimes the law requires us to share your information, such as if we receive a valid subpoena, warrant, or court order. On such occasions, we will share your information if: (1) Our careful review leads us to believe that the subpoena, warrant, or court order is valid, and that the law, including state privacy law applicable to Library records, requires us to do so; (2) Creative Biogene is the complainant; (3) Exigent circumstances exist (for example, a life-and-death emergency or the risk of serious physical injury). If Creative Biogene receives a valid subpoena, warrant, or court order for a patron's information, it is our policy to notify the patron via email before any information is disclosed, with certain exceptions such as being required by authorities not to contact the patron, or if we have no way to contact the patron.
Third-party vendors and websites. We may use third-party service providers and technologies to help deliver some of our services to you. We will make every effort to let you know when a third-party company is being used to deliver our services. If and when you choose to use such services, we may need to share your information with these third parties, but only as necessary for them to provide the services on behalf of Creative Biogene.
Investors and other contributors. We are often only able to provide certain products and services, which we would not otherwise be able to afford, due to the generous support of investors and other contributors. These funds are occasionally dependent upon Creative Biogene complying with the reporting requirements of the investor or contributor. If you participate in these services, your information may be included in these reports. When appropriate and practical, we will tell you the names of investors and contributors associated with these products and services, as well as what data and information we may need to share with them, in the registration process.
We do not sell, trade, or rent your personal information for commercial purposes without your consent. We do not disclose information about identifiable individuals to anyone else except as set out above.
The Children's Online Privacy Protection Act (COPPA) regulates online collection of information from children under the age of 13. If you are under the age of 13, you may not be allowed to use our online services without your parent's or guardian's permission, especially when your personal information may be automatically collected. Parents and guardians of children under the age of 13 may view their children's website records. Parents and guardians of children between the ages of 13 and 17 (inclusive) may also view their children's website records, but require their children's consent to do so. In the case we discover that a child under 13 has provided us with personal information, we immediately delete this from our servers. If you are a parent or guardian and you are aware that your child has provided us with personal information, please contact us so that we can take the necessary actions.
Our Service may contain links to other sites. If you click on a third-party link, you will be directed to that site. Please note that these external sites are not operated by us. Therefore, we strongly advise you to review the Privacy Policy of these websites. We have no control over and assume no responsibility for the content, privacy policies, or practices of any third-party sites or services.
Your personal information may be transferred to our group companies or service providers that are based outside your home country for the purposes described in this Privacy Notice.
If your personal data is transferred, it will continue to be subject to one or more appropriate safeguards.
In certain circumstances, subject to certain restrictions and applicable law, you may have the following data protection rights:
We keep this Privacy Notice under regular review and may update it from time to time. If we make any changes, we will take appropriate measures such as by placing a notice on our website, sending you an email, and/or some other means to inform you or to obtain your consent, if and where this is required by applicable data protection laws.
Last updated January 22, 2024
If you have any questions or concerns about our use of your personal information, or want to exercise any of your rights, please contact us by email at .
Copyright © Creative Biogene. All rights reserved.